Literature DB >> 11358994

Role of mitogen-activated protein kinases in the differential regulation of interleukin-2 by cannabinol.

T R Jan1, N E Kaminski.   

Abstract

Cannabinoids can paradoxically regulate interleukin-2 (IL-2) expression either positively or negatively. This study investigated the mechanism responsible for cannabinol-mediated IL-2 modulation. In primary murine splenocytes and EL4.IL-2 T cells, the contrasting effects of cannabinol on IL-2 secretion depended on the magnitude but not the mode of T-cell activation. Suboptimal activation of T cells in the presence of cannabinol produced an enhancement of IL-2 secretion, which was paralleled by an increase in nuclear phospho-extracellular-regulated kinase (ERK) 1/2. In contrast, T cells activated with stimuli that were optimized to induce maximal IL-2 secretion elicited a marked suppression in the production of this cytokine when cultured in the presence of cannabinol. Moreover, cannabinol-mediated enhancement of IL-2 secretion by splenocytes was attenuated to various degrees by staurosporine, Ro-31-8220, and KN93. These results suggest that the enhancement of IL-2 secretion by cannabinol is associated with an increase in ERK mitogen-activated protein kinase, which is protein kinase C and calmodulin-kinase dependent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11358994

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol.

Authors:  Weimin Chen; Robert B Crawford; Barbara L F Kaplan; Norbert E Kaminski
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-22       Impact factor: 4.147

2.  Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120.

Authors:  Weimin Chen; Barbara L F Kaplan; Schuyler T Pike; Lauren A Topper; Nicholas R Lichorobiec; Steven O Simmons; Ram Ramabhadran; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2012-08-16       Impact factor: 4.962

3.  Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.

Authors:  Saphala Dhital; John V Stokes; Nogi Park; Keun Seok Seo; Barbara L F Kaplan
Journal:  Cell Immunol       Date:  2016-11-09       Impact factor: 4.868

4.  Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.

Authors:  Haitian Lu; Barbara L F Kaplan; Thitirat Ngaotepprutaram; Norbert E Kaminski
Journal:  J Leukoc Biol       Date:  2008-11-06       Impact factor: 4.962

5.  Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells.

Authors:  E Gkoumassi; B G J Dekkers; M J Dröge; C R S Elzinga; M Schmidt; H Meurs; J Zaagsma; S A Nelemans
Journal:  Br J Pharmacol       Date:  2007-06-11       Impact factor: 8.739

6.  Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.

Authors:  Peer W F Karmaus; James G Wagner; Jack R Harkema; Norbert E Kaminski; Barbara L F Kaplan
Journal:  J Immunotoxicol       Date:  2012-11-23       Impact factor: 3.000

Review 7.  Immune Responses Regulated by Cannabidiol.

Authors:  James M Nichols; Barbara L F Kaplan
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

Review 8.  Cannabis and Autoimmunity: Possible Mechanisms of Action.

Authors:  Valeria Giorgi; Daniela Marotto; Alberto Batticciotto; Fabiola Atzeni; Sara Bongiovanni; Piercarlo Sarzi-Puttini
Journal:  Immunotargets Ther       Date:  2021-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.